Skip to main content
Clinical Trials/NCT04920461
NCT04920461
Unknown
Not Applicable

Visual-spatial and Visual-perceptual Disorders Following Cerebellar Strokes

Centre Hospitalier Universitaire de Besancon1 site in 1 country42 target enrollmentApril 16, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stroke, Ischemic
Sponsor
Centre Hospitalier Universitaire de Besancon
Enrollment
42
Locations
1
Primary Endpoint
Presence of Neuro-Visual Disorder
Last Updated
4 years ago

Overview

Brief Summary

This study aims at assessing the proportion of patients suffering from neuro-visual troubles (visual-spatial and/or visual-perceptual ), after cerebellar strokes.

Registry
clinicaltrials.gov
Start Date
April 16, 2020
End Date
July 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Signed informed consent form
  • Being able to pass initial neuropsychological tests within 10 days after stroke

Exclusion Criteria

  • Previous central neural system/psychiatric/eye disease (including severe cranial trauma)
  • Chronic alcoholism
  • MRI contraindication.

Outcomes

Primary Outcomes

Presence of Neuro-Visual Disorder

Time Frame: Month 3

Presence of neuro-visual disorder will be confirmed by obtaining at least 2 pathological scores at following neuropsychological tests: * Rey \& Taylor figures (score from 0 to 36, maximum) * Judgment of Line Orientation (score from 0 to 36, maximum) * Weschler Adult Intelligence Scale (final score is intelligence quotient, with an average score is fixed at 100) * Test of Attentional Performance * Visual Object and Space Perception Battery (eight tests each designed to assess a particular aspect of object or space perception, while minimising the involvement of other cognitive skills) * Visual agnosia assesment protocole (noted on 10 points)

Study Sites (1)

Loading locations...

Similar Trials